Cytokinetics Stock Target Price and Analyst Consensus

CYTK -  USA Stock  

USD 38.65  3.50  8.30%

The current analyst and expert consensus on Cytokinetics is Buy, with 0 strong sell and 8 strong buy opinions. The current projected Cytokinetics target price consensus is 54.67 with 12 analyst opinions. The most common way Cytokinetics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Cytokinetics executives and customers to further validate their buy or sell advice. Cytokinetics buy-or-sell recommendation module provides average expert sentiment on the projected Cytokinetics target price to derive its highest and lowest estimates based on projected price volatility of 9.604. Continue to Macroaxis Advice on Cytokinetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
The current Gross Profit is estimated to decrease to about 59.3 M. The current Profit Margin is estimated to decrease to -3.3. Cytokinetics Assets Non Current are increasing as compared to previous years. The last year's value of Assets Non Current was reported at 305.65 Million. The current Total Debt is estimated to increase to about 291.2 M, while Cash and Equivalents is projected to decrease to under 91.2 M.

Cytokinetics Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cytokinetics target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cytokinetics target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions11
Lowered Outlook0
Raized Outlook0
Buy
Most Cytokinetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cytokinetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cytokinetics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Cytokinetics Target Price Projection

Cytokinetics' current and average target prices are 38.65 and 54.67, respectively. The current price of Cytokinetics is the price at which Cytokinetics is currently trading. On the other hand, Cytokinetics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Cytokinetics Market Quote on 18th of May 2022

Low Price38.45Odds
High Price42.16Odds

38.65

Target Price

Analyst Consensus On Cytokinetics Target Price

Low Estimate40.0Odds
High Estimate75.0Odds
Number of Analysts12
Standard Deviation9.604

54.666

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Cytokinetics and the information provided on this page.

Cytokinetics Analyst Ratings

Cytokinetics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Cytokinetics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Cytokinetics' financials, market performance, and future outlook by experienced professionals. Cytokinetics' historical ratings below, therefore, can serve as a valuable tool for investors.

Average Consensus Estimates

About Cytokinetics Target Price Projections

Cytokinetics's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Cytokinetics and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Cytokinetics depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Cytokinetics including analysis of its current option contracts.
Cytokinetics' latest option contracts expiring on 2022-05-20 are carrying combined implied volatility of 101.31 with a put-to-call open interest ratio of 0.61 over 72 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2022-05-20. The current put volume is at 139, with calls trading at the volume of 141. This yields a 0.99 put-to-call volume ratio. The Cytokinetics option chain provides detailed quote and price information for the current Cytokinetics option contracts. It shows all of Cytokinetics' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-05-20 Option Contracts

Cytokinetics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Cytokinetics' lending market. For example, when Cytokinetics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Cytokinetics, he or she must hedge the risk by shorting Cytokinetics stock over its option's life.
The chart above shows Cytokinetics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Cytokinetics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Cytokinetics' option, there is no secondary market available for investors to trade.

Cytokinetics Maximum Pain Price across 2022-05-20 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Cytokinetics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Cytokinetics' stock options are financial instruments that give investors the right to buy or sell shares of Cytokinetics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Cytokinetics stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Cytokinetics' stock price goes up or down, the stock options follow.
Continue to Macroaxis Advice on Cytokinetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Cytokinetics In The Money Call Balance

When Cytokinetics' strike price is surpassing the current stock price, the option contract against Cytokinetics stock is said to be in the money. When it comes to buying Cytokinetics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' options written on Cytokinetics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Cytokinetics Current Options Market Mood

Cytokinetics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Cytokinetics Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Cytokinetics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Cytokinetics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Cytokinetics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Cytokinetics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cytokinetics is a key component of Cytokinetics valuation and have some predictive power on the future returns of a Cytokinetics.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cytokinetics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
35.6939.9244.15
Details
Intrinsic
Valuation
LowReal ValueHigh
35.5546.6050.83
Details
Earnings
Estimates (8)
LowProjected EPSHigh
-3.44-3.23-2.91
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cytokinetics. Your research has to be compared to or analyzed against Cytokinetics' peers to derive any actionable benefits. When done correctly, Cytokinetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cytokinetics.

Additional Cytokinetics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cytokinetics is a key component of Cytokinetics valuation and have some predictive power on the future returns of a Cytokinetics.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cytokinetics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
35.6939.9244.15
Details
Intrinsic
Valuation
LowReal ValueHigh
35.5546.6050.83
Details
Earnings
Estimates (8)
LowProjected EPSHigh
-3.44-3.23-2.91
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cytokinetics. Your research has to be compared to or analyzed against Cytokinetics' peers to derive any actionable benefits. When done correctly, Cytokinetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cytokinetics.

Currently Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Cars
Invested over 70 shares
Blockchain
Invested few shares
Technology
Invested over 20 shares
Momentum
Invested few shares
Macroaxis Index
Invested over 20 shares
Continue to Macroaxis Advice on Cytokinetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
The data published in Cytokinetics' official financial statements usually reflect Cytokinetics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Cytokinetics. For example, before you start analyzing numbers published by Cytokinetics accountants, it's critical to develop an understanding of what Cytokinetics' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Cytokinetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cytokinetics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Cytokinetics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cytokinetics. Please utilize our Beneish M Score to check the likelihood of Cytokinetics' management to manipulate its earnings.